Showing results (361-370 of 370) with videos related to
Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 370 results.
Bioorganic & Medicinal Chemistry|February 5, 2000
Model studies on a synthetically facile series of N-substituted phenyl-N'-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT(2C/2B) receptor antagonistsS M Bromidge, S Dabbs, D T Davies, et al.Journal of Medicinal Chemistry|May 30, 1998
Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolinesS M Bromidge, S Dabbs, D T Davies, et al.American Journal of Public Health|June 21, 2022
Integrated Surveillance System for Controlling COVID-19 on a University Campus, 2020‒2021Genevive R Meredith, Marwan Osman, Casey L Cazer, et al.AJPM Focus|February 21, 2024
Representative Public Health Surveys Pose Several Challenges: Lessons Learned Across 9 Communities During the COVID-19 PandemicJeanne W Lawless, Diego G Diel, Bettina Wagner, et al.Journal of Medicinal Chemistry|March 29, 2000
Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agentS M Bromidge, S Dabbs, D T Davies, et al.Nature Communications|December 3, 2024
A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmissionNatalya Kostandova, Catherine Schluth, Rohan Arambepola, et al.Science Advances|August 30, 2024
Discovery of SARS-CoV-2 papain-like protease (PLpro) inhibitors with efficacy in a murine infection modelMichelle R Garnsey, Matthew C Robinson, Luong T Nguyen, et al.Applied Optics|May 11, 2010
Research on nonlinear optical materials: an assessmentD H Auston, A A Ballman, P Bhattacharya, et al.MMWR. Morbidity and Mortality Weekly Report|May 14, 2021
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021Rebecca K Borchering, Cécile Viboud, Emily Howerton, et al.Proceedings of the National Academy of Sciences of the United States of America|April 8, 2022
Evaluation of individual and ensemble probabilistic forecasts of COVID-19 mortality in the United StatesEstee Y Cramer, Evan L Ray, Velma K Lopez, et al.Pageof 37